Astrazeneca
Anglo-Swedish pharma major with a deep oncology and respiratory pipeline.
Coverage of Astrazeneca is holding steady : 2 signals on the latest tracked day, down 33% from its three-week baseline of 3, across 2 domains (down from 3 a week ago). That makes it the #253 most-covered of the 349 concerns we track.
What’s changed
5 of the last 7 tracked days ran above the three-week baseline — a sustained move, not a one-day spike.
- AstraZeneca healthcare benefits? · Reddit r/biotech · 2026-08-21
- Astrazeneca interview · Reddit r/biotech · 2026-08-19
- STAT+: Pharmalittle: We’re reading about an AstraZeneca setback, falling U.S. drug prices, and more · STAT News — All Content · 2026-08-18
- AstraZeneca touts Enhertu, Orpathys dual lung cancer wins amid bispecific failure · Fierce Pharma · 2026-08-18
- Canada Biotech: GSK or Astrazeneca · Reddit r/biotech · 2026-08-15
- Has anyone interacted with "Elisa Daura" from AstraZeneca? · Reddit r/biotech · 2026-08-14
What the reporting says
Across 41 tracked stories from 14 outlets, reporting on Astrazeneca most often describes regulatory approvals (5), IPOs or listings (1), military action (1), meetings or visits (1), public statements (1).
It shows up alongside Bristol Myers Squibb (14), Merck (13), FDA (12), Abstract (11), Eli Lilly (8), Immunotherapy (8).
Two steps out: Moderna (through Merck, 13 shared stories on the weaker link); AI (through Merck, 12 shared stories on the weaker link); Cder (through FDA, 12 shared stories on the weaker link); Colorectal Cancer (through FDA, 12 shared stories on the weaker link).
Tracked since Apr 12, with coverage on 24 separate days — concentrated in Preprint and FDA Decisions.